Enhance Decision-Making When Prescribing Medications for Psychiatric Conditions

  • Treatment decisions guided by genetic test results can offer a personalized and more precise treatment plan.

  • Less than 1/3 of depressed patients respond to their initial antidepressant.¹

  • The genes analyzed in the MyPGt™ test are associated with a wide range of medications and can help to inform treatment plans for psychiatric illnesses.

  • Order the MyPGt™ panel for mental health patients.

 
 
 

MyPGt™ Genotype Report Helps You:

•Minimize the trial and error method of drug therapy

•Reduce adverse drug reactions

•Improve patient care

 

References:
¹N Engl J Med. 2006 Mar 23;354(12):1231-42. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.